Trinity Biotech(TRIB) - 2022 Q4 - Annual Report

Exhibit 99.1 Press Release dated December 15, 2022 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Q3 2022 Financial Results DUBLIN, Ireland (December 15, 2022)... Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company's results for the quarter ended September ...